Skip to content

High Flow Nasal Cannula for Safe Apnea

Effect of High-flow Nasal Oxygenation on Safe Apnea Time in Children With Open Mouth

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04849520
Enrollment
38
Registered
2021-04-19
Start date
2021-08-12
Completion date
2023-03-21
Last updated
2023-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, General, Apnea

Keywords

Oxygenation, High-flow nasal cannula

Brief summary

This is a prospective randomized controlled trial comparing high flow nasal cannula and buccal oxygenation as method of oxygenation during apnea in children.

Detailed description

This is a prospective randomized controlled trial comparing two oxygenation methods for prolongation of apnea time in children aged 0 to 10 years old. This study measures time for the pulse oximetry drop from 100% to 92% after oxygenation with 100% oxygen, applying high flow nasal cannula or buccal oxygen insufflation via an oral Ring-Adair-Elwyn endotracheal tube connected to oxygen.

Interventions

DEVICEHigh flow nasal cannula

Oxygen supplement via high flow nasal cannula at a rate of 2 liters/kg/min

DEVICEBuccal oxygenation

Oxygen supplement intra-orally via oral Ring-Adair-Elwyn endotracheal tube connected to oxygen at a rate of 0.5 liters/kg/min

Sponsors

National Evidence-Based Healthcare Collaborating Agency
CollaboratorOTHER_GOV
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Intervention model description

Prospective randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
No minimum to 10 Years
Healthy volunteers
No

Inclusion criteria

* Children under 11 years old undergoing general anesthesia with American Society of Anesthesiologists Physical Status 1 or 2.

Exclusion criteria

* Refusal of enrollment from one or more legal guardians of the patient * Plan of usage of supraglottic airway device as airway maintenance device * Presence of upper respiratory tract infection of lung disease * Premature infants younger than postconceptual age of 40 weeks * Anticipation of difficult bag-mask ventilation due to facial anomaly or micrognathia * Other conditions that are considered inappropriate for the study

Design outcomes

Primary

MeasureTime frameDescription
Apnea success rateFrom start of apnea to drop of pulse oximetry to 92%, up to 520 secondsProportion of patients that succeed in prolongation of apnea time while maintaining pulse oximetry \> 92%

Secondary

MeasureTime frameDescription
Pulse oximetryFrom start of study to end of study, up to 20 minPulse oximetry measured throughout the study
Oxygen reserve indexFrom start of study to end of study, up to 20 minOxygen reserve index measured throughout the study
Apnea timeFrom start of apnea to drop of pulse oximetry to 92%, up to 520 secondsTime elapsed from start of apnea to resume of bag-mask ventilation
End-tidal carbon dioxideAfter resuming of bag-mask ventilation, up to 30 secondsEnd-tidal carbon dioxide partial pressure of first resumed breath after apnea
Mean blood pressureFrom start of study to end of study, up to 20 minMean non-invasive blood pressure measured throughout the study
Time to pulse oximetry of 100 percentAfter resuming of bag-mask ventilation, up to 300 secondsTime elapsed from resume of bag-mask ventilation to regain of 100 percent in the pulse oximetry value
ElectrocardiogramFrom start of study to end of study, up to 20 minAppearance of any arrhythmia or prolonged QT interval measured throughout the study
Transcutaneous carbon dioxideFrom start of study to end of study, up to 20 minTranscutaneous carbon dioxide level measured throughout the study
Heart rateFrom start of study to end of study, up to 20 minHeart rate measured throughout the study
Minimal pulse oximetryAfter resuming of bag-mask ventilation, up to 60 secondsLowest value of pulse oximetry after resume of bag-mask ventilation

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026